ACCESS UNCONJUGATED ESTRIOL REAGENT 33570

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2015-10-27 for ACCESS UNCONJUGATED ESTRIOL REAGENT 33570 manufactured by Beckman Coulter.

Event Text Entries

[30122445] The customer did not provide patient demographics such as age, date of birth or weight. The access unconjugated estriol reagent was not returned for evaluation. All assay and system verifications met specifications. The cause of this event cannot be determined with the available information.
Patient Sequence No: 1, Text Type: N, H10


[30122446] The customer reported one (1) non-reproducibly elevated unconjugated estriol (access unconjugated estriol) result which was obtained on the laboratory's access 2 immunoassay system (serial number (b)(4)) for one (1) patient. The access unconjugated estriol was performed as part of a maternal serum triple screening test. The screening was performed on (b)(6) 2015 and an initial access unconjugated estriol result of 0. 5 nmol/l was obtained. The same sample was repeated as part of the laboratory's repeat protocol for access unconjugated estriol results of less than 1. 0 nmol/l and results of 5. 34 nmol/l and 0. 53 nmol/l were obtained. Per the customer, the lower access unconjugated estriol results were correct as the results met the clinical presentation of the patient. The results were not released from the laboratory. There were no reports of patient injury or change to patient treatment associated with this event. System parameters including calibration, quality control (qc) and system checks were within assay/instrument specifications. There were no errors posted in the event log. A precision run was performed using low control qc. The precision run met assay and system specifications. Alpha-fetoprotein (access afp) and human chorionic gonadotropin (access total bhcg (5th is)) tests were also performed as part of the maternal serum screening. Results for both assays were reproducible and not questioned. The sample was collected in a becton dickinson (bd) serum separator tube (sst) and was spun prior to arriving at the lab for testing. Sample processing information was not provided. The original serum tube was pulled and inspected. No issues with sample integrity were reported by the customer.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2122870-2015-00699
MDR Report Key5180711
Date Received2015-10-27
Date of Report2015-10-02
Date of Event2015-10-01
Date Mfgr Received2015-10-02
Device Manufacturer Date2015-02-01
Date Added to Maude2015-10-27
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. JEFFREY KOLL
Manufacturer Street1000 LAKE HAZELTINE DRIVE
Manufacturer CityCHASKA MN 55318
Manufacturer CountryUS
Manufacturer Postal55318
Manufacturer Phone9523681361
Manufacturer G1BECKMAN COULTER
Manufacturer Street1000 LAKE HAZELTINE DRIVE
Manufacturer CityCHASKA 55318
Manufacturer CountryUS
Manufacturer Postal Code55318
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report0

Device Details

Brand NameACCESS UNCONJUGATED ESTRIOL REAGENT
Generic NameRADIOIMMUNOASSAY, ESTRIOL
Product CodeCGI
Date Received2015-10-27
Model NumberNA
Catalog Number33570
Lot Number437160
Device Expiration Date2017-01-31
OperatorHEALTH PROFESSIONAL
Device Availability*
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerBECKMAN COULTER
Manufacturer Address1000 LAKE HAZELTINE DRIVE CHASKA 55318 US 55318


Patients

Patient NumberTreatmentOutcomeDate
10 2015-10-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.